Advicenne Logo


ISIN: FR0013296746 | Ticker: ALDVI | LEI: 969500YT5VMEYAYODW34
Sector: Health CareSub-Industry: Biotechnology
Country: France

About Advicenne

Company Description

For more than 10 years, Advicenne has been dedicated to developing innovative, effective and safe treatments for people living with rare renal diseases who have very limited therapeutic options. Thanks to our expertise in reformulation and drug delivery, we are uniquely positioned to develop and make available innovative treatments for both children and adults with rare renal diseases.

At Advicenne we are dedicated to improving patients’ daily health and life. Our employees in France and the United States are committed to tackle the challenge of high unmet medical need to improve quality of life for patients and their caregivers.

Sibnayal® (combination of Potassium citrate and Potassium bicarbonate) was in 2021 approved by the European Medicine Agency and MHRA.

Served area



3ème étage 262 Rue du Faubourg Saint-Honoré, 75008 Paris – France

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
04.10.23 None Other Other EUR 3,499,999.62
04.10.23 None Other Buy EUR 99,998.13
02.10.23 None Other Other EUR 999,998.17
21.09.23 None Other Sell EUR 22.34
15.09.23 None Other Sell EUR 13.45

Capital markets information






Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences





Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.